SAN FRANCISCO – Shareholders brought a federal derivative lawsuit against McKesson Corp. and its top executives and directors for the $150 million settlement with the Drug Enforcement Administration announced two weeks ago, for violations of the Controlled Substances Act.
Categories / Securities
Subscribe to our free newsletters
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.
Additional Reads
-
-
Contempt for Musk clouds jury selection in Twitter takeover trial February 19, 2026
-
Ups and downs for Boeing investors February 18, 2026 -
